Daily low-dose cisplatin and concurrent thoracic irradiation for poor-risk patients with unresectable non-small-cell lung cancer

Acta Medica Okayama

Volumn 56, Issue 5, 2002, Pages 261-266

  Takata, Ichiro ^a   Ueoka, Hiroshi ^a   Kiura, Katsuyuki ^a   Tabata, Masahiro ^a   Takigawa, Nagio ^a   Katayama, Hideki ^a   Takemoto, Mitsuhiro ^a   Hiraki, Yoshio ^a   Harada, Mine ^b   Tanimoto, Mitsune ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Concurrent chemoradiotherapy; Low dose cisplatin; Non small cell lung cancer; Poor risk factor

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADENOCARCINOMA; AGED; ARTICLE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; THORAX;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; THORAX;

EID: 0036824480     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, Shopland DR, Thun MJ and Edwards BK: Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst (1999) 91, 675-690.
2. Gould C and Sause WT: Radiation therapy for lung cancer; in Lung cancer, Johnson BE and Johnson DH eds, Wiley-Liss, New York (1995) pp 191-207.
3. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF IIIrd and Green MR: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med (1990) 323, 940-945.
4. Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, Lacombe-Terrier MJ, Douillard JY and Laplanche A: Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresecta ble non-small-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst (1991) 83, 417-423.
5. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, Dar AR and Cox JD: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced unresectable non-small-cell lung cancer. J Natl Cancer Inst (1995) 87, 198-205.
6. Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ (1995) 311, 899-909.
7. Furuse K, Fukuoka M, Kawahara M Nishikawa H, Takada Y, Kudoh S, Katagami N and Ariyoshi Y: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vin-desine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol (1999) 17, 2692-2699.
8. Curran W, Scot C, Langer C, Komaki R, Lee J, Hauser S, Movsas B, Wasserman TH, Rosenthal S, Byhardt R, Sause W and Cox J: Phase III comparison of sequential vs concurrent chemoradiation for patients (Pts) with unresected stage III non-small cell lung cancer (NSCLC): Initial report of Radiation Therapy Oncology Group (RTOG) 9410 [Abstract]. Proc Am Soc Clin Oncol (2000) 19, 484a.
9. Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S and Harada M: A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: A preliminary report from the Okayama Lung Cancer Study Group. Br J Cancer (2000) 82, 104-111.
10. Dewit L: Combined treatment of radiation and cisdiamminedichloroplatinum (II): A review of experimental and clinical data. Int J Radiat Oncol Biol Phys (1987) 13, 403-426.
11. Broven E, Tierie AH, Stam J and Pinedo HM: Combined radiation therapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer: Results of a phase II trial. Semin Oncol (1988) 15 (Suppl 7), 18-19.
12. Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A, Renaud A, Rodrigus P, Schuster-Uitterhoeveb L, Sculier JP, van Zandwijk N and Bartelink H: Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med (1992) 326, 524-530.
13. Trovo MG, Minatel E, Franchin G, Boederi MG, Nascimben O, Bolzicco G, Pizzi G, Torretta A, Veronesi A, Gobitti C, Zanelli DJ and Monfardini: Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys (1992) 24, 11-15.
14. Hazuka MB, Crowley JJ, Bunn PA Jr, O'Rourke M, Braun TJ and Livingston RB: Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: Results of a phase II Southwest Oncology Group study. J Clin Oncol (1994) 12, 1814-1820.
15. Schuster-Uitterhoeve AL, van de Vaart PJ, Schaake-Koning CC, Benraadt J, Koolen MG, Gonzalez Gonzalez D and Bartelink H: Feasibility of escalating daily doses of cisplatin in combination with accerelated radiotherapy in non-small cell lung cancer. Eur J Cancer (1996) 32A, 1314-1319.
16. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 5, 649-655.
17. Miller AB, Hoogstraten B, Staquet M and Winkler: Reporting results of cancer treatment. Cancer (1981) 47, 207-214.
18. Cox JD, Stetz J and Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys (1995) 31, 1341-1346.
19. Choy H, Safran H, Akerley W, Graziano SL, Bogart JA and Cole BF: Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer. Clin Cancer Res (1998) 4, 1931-1936.
20. Mauer AM, Masters GA, Haraf DJ, Hoffman PC, Watson SM, Golomb HM and Vokes EE: Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol (1998) 16, 159-164.
21. Jeremic B, Shibamoto Y, Acimovic L and Milisavljevic S: Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized study. J Clin Oncol (1996) 14, 1065-1070.